Cargando…
Evolution of the Vagus Nerve Stimulation (VNS) Therapy System Technology for Drug-Resistant Epilepsy
The vagus nerve stimulation (VNS) Therapy® System is the first FDA-approved medical device therapy for the treatment of drug-resistant epilepsy. Over the past two decades, the technology has evolved through multiple iterations resulting in software-related updates and implantable lead and generator...
Autores principales: | Afra, Pegah, Adamolekun, Bola, Aydemir, Seyhmus, Watson, Glenn David Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757869/ https://www.ncbi.nlm.nih.gov/pubmed/35047938 http://dx.doi.org/10.3389/fmedt.2021.696543 |
Ejemplares similares
-
Update on once-daily zonisamide monotherapy in partial seizures
por: Afra, Pegah, et al.
Publicado: (2014) -
Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug‐resistant epilepsy enrolled in a Russian VNS Registry
por: Feygina, Anna A., et al.
Publicado: (2023) -
Vagus Nerve Stimulator (VNS)-induced Severe Obstructive Sleep Apnea Which Resolved After the VNS Was Turned Off
por: Gurung, Puja, et al.
Publicado: (2020) -
Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience
por: Magis, D, et al.
Publicado: (2013) -
Transcutaneous Vagus Nerve Stimulation (tVNS) and the Dynamics of Visual Bistable Perception
por: Keute, Marius, et al.
Publicado: (2019)